I know Facebook exists, but I am not part of its ever-growing half-a-billion member network. But a pharma company apparently is. Novartis — maker of such patented mainstays as Lotrel and hot seller Diovan — was sent a notice by the FDA in which the government agency accused the drugmaker of violating Facebook terms in relation to their misleading potential consumers over a leukemia drug.

Once the drug info is viewed on the popular social network, users can spread the word about all of its benefits, but about none of its risks. In the ad for the drug, claims were made that it outperforms other anti-leukemia drugs on the market; those claims have not been proven. | PDF LINK

Related Posts Within Doctor Pundit:

1. Pharma Using Physician Social Networks as Potential Marketing Opportunity Has the need for attention and online social contacts been...
2. Report: Pharma Company Covered Up Known Cardiovascular Risks of Drug GSK (then known as SmithKline Beecham) knew in a 1999...
3. Pharma Company Forges Partnership to Create Genetic Therapies for Rare Diseases In an otherwise dull year for novel drug development, GSK...
4. Pharma Company to Pay Over $900M from Vioxx Marketing Practices The DOJ decision has been handed down. Merck Co. will...
5. Pharma Company Strives to Keep Star Performing Drug Close Twenty-eleven and 2012 are going to be remembered in the...